Cargando…
Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis
We aim to explore the associations between matrix metalloproteinase (MMP) MMP-2/MMP-9 gene polymorphism with ulinastatin (UTI) efficacy in treating severe acute pancreatitis (SAP). A total of 276 SAP patients were assigned into the control (n=135) and observation (n=141) groups. PCR-restriction frag...
Autores principales: | Zhen, Guo-Dong, Zhao, Lian-Bin, Wu, Shan-Shan, Chen, Ming-Yu, Li, Zhen-He, Zhou, Sheng-Zhi, Li, Zhen-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569160/ https://www.ncbi.nlm.nih.gov/pubmed/28779012 http://dx.doi.org/10.1042/BSR20160612 |
Ejemplares similares
-
MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis
por: Ling, Lan, et al.
Publicado: (2019) -
The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2014) -
Efficacy of ulinastatin for the treatment of patients with severe acute pancreatitis
por: Yao, Jian-hui, et al.
Publicado: (2019) -
Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk
por: Zhang, Caiyun, et al.
Publicado: (2013) -
Functional polymorphisms in the promoter region of MMP-2 and MMP-9 and susceptibility to obstructive sleep apnea
por: Cao, Chao, et al.
Publicado: (2015)